Neuronetics Launches First Inaugural National TMS Therapy Awareness Day During Mental Health Awareness Month

Neuronetics, Inc., a vertically integrated, commercial-stage medical technology and health care company, launched the first national transcranial magnetic stimulation (TMS) therapy awareness day. The event will take place each year on May 14 during the larger observation of Mental Health Awareness Month in May. National TMS Therapy Awareness Day is intended to raise awareness of TMS therapy as a non-drug treatment option for people living with major depressive disorder (MDD), depression with anxiety, and OCD, especially those who have not found relief through antidepressants.

Neuronetics developed and markets the NeuroStar TMS therapy device, which was first cleared by . . .